Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Medshine Discovery identifies new ERK-2 inhibitors

June 30, 2021

Shanghai Yingli Pharmaceutical describes new GTPase KRAS inhibitors

June 30, 2021

Wigen Biomedicine Technology presents new Aurora kinase inhibitors

June 30, 2021

Interim data from phase II CORIST study of SCO-101 in metastatic colorectal cancer

June 29, 2021

Ideaya provides clinical updates for IDE-397 phase I study and darovasertib combination trial

June 29, 2021

First-in-human study finds CEB-01 implant safe in patients with retroperitoneal soft tissue sarcoma

June 29, 2021

New PRMT5 inhibitors discovered at Lupin

June 29, 2021

Cadila Healthcare discovers NLRP3 inflammasome inhibitors

June 29, 2021

New Raf kinase C inhibitors identified at Medshine Discovery

June 29, 2021

DSMB recommends continuation of phase Ib study of microbiome ecosystem therapy MaaT-033 in AML

June 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...